Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia Henrie-Barrus

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Health Psychology Open|January 11, 2017
Development and preliminary validation of the Opioid Abuse Risk ScreenerPatricia Henrie-Barrus, Lynnette A Averill, Richard R Sudweeks, et al.
Frontiers in Psychiatry|December 6, 2021
Case Report: Unexpected Remission From Extreme and Enduring Bulimia Nervosa With Repeated Ketamine Assisted PsychotherapyAnya Ragnhildstveit, Laura Kate Jackson, Sarah Cunningham, et al.
Health Psychology Open|January 31, 2018
The Opioid Abuse Risk Screener predicts aberrant same-day urine drug tests and 1-year controlled substance database checks: A brief reportLynnette A Averill, Christopher L Averill, Lyndsay A Staley, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Health Psychology Open|January 11, 2017
Development and preliminary validation of the Opioid Abuse Risk ScreenerPatricia Henrie-Barrus, Lynnette A Averill, Richard R Sudweeks, et al.
Frontiers in Psychiatry|December 6, 2021
Case Report: Unexpected Remission From Extreme and Enduring Bulimia Nervosa With Repeated Ketamine Assisted PsychotherapyAnya Ragnhildstveit, Laura Kate Jackson, Sarah Cunningham, et al.
Health Psychology Open|January 31, 2018
The Opioid Abuse Risk Screener predicts aberrant same-day urine drug tests and 1-year controlled substance database checks: A brief reportLynnette A Averill, Christopher L Averill, Lyndsay A Staley, et al.
Pageof 1